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EXTENDED REPORT
B cell OX40L supports T follicular helper cell 
development and contributes to SLE pathogenesis
Andrea Cortini,1 Ursula Ellinghaus,1 Talat H Malik,2 Deborah S Cunninghame Graham,1 
Marina Botto,2 Timothy James Vyse1
ABSTRACT
Objectives  TNFSF4 (encodes OX40L) is a susceptibility 
locus for systemic lupus erythematosus (SLE). Risk 
alleles increase TNFSF4 expression in cell lines, but the 
mechanism linking this effect to disease is unclear, and 
the OX40L-expressing cell types mediating the risk are 
not clearly established. Blockade of OX40L has been 
demonstrated to reduce disease severity in several 
models of autoimmunity, but not in SLE. We sought to 
investigate its potential therapeutic role in lupus.
Methods We used a conditional knockout mouse 
system to investigate the function of OX40L on B and T 
lymphocytes in systemic autoimmunity.
Results Physiologically, OX40L on both B and T cells 
contributed to the humoral immune response, but B cell 
OX40L supported the secondary humoral response and 
antibody afﬁnity maturation. Our data also indicated 
that loss of B cell OX40L impeded the generation of 
splenic T follicular helper cells. We further show that in 
two models of SLE—a spontaneous congenic model and 
the H2-IAbm12 graft-versus-host-induced model—loss of 
B cell OX40L ameliorates the autoimmune phenotype. 
This improvement was, in each case, accompanied by a 
decline in T follicular helper cell numbers. Importantly, 
the germline knockout did not exhibit a markedly 
different phenotype from the B cell knockout in these 
models.
Conclusions These ﬁndings contribute to a model 
in which genetically determined increased OX40L 
expression promotes human SLE by several mechanisms, 
contingent on its cellular expression. The improvement 
in pathology in two models of systemic autoimmunity 
indicates that OX40L is an excellent therapeutic target 
in SLE.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a chronic 
autoimmune disease characterised by autoanti-
bodies against nuclear antigens along with the depo-
sition of immune complexes.1 2 As with most other 
autoimmune diseases, environmental and genetics 
factors contribute to the risk of developing SLE. 
Genome-wide association studies have revealed 
over 50 susceptibility loci.3 4 TNFSF4 (tumour 
necrosis factor ligand family, member 4, CD252) is 
an established susceptibility gene for SLE4 5 and for 
several other autoimmune diseases.6–9 Fine-map-
ping of this locus in SLE identified two indepen-
dent association signals upstream of TNFSF4 in 
multiple ancestries.10 These two signals align with 
separate expression quantitative trait loci, each one 
associated with elevated expression of TNFSF4 
in Epstein Barr virus (EBV) lymphoblastoid cell 
lines,11 suggesting that TNFSF4 transcription is 
upregulated in individuals harbouring risk alleles.
TNFSF4 encodes the costimulatory molecule, 
OX40L, a type II transmembrane protein expressed 
on several immune cell types on activation, 
including anitigen presenting cells (APCs), such as 
dendritic cells (DCs), B cells and macrophages,12–14 
activated T cells,15 16 and mast cells and vascular 
endothelial cells.17 In contrast, its only known 
receptor, OX40, is expressed mainly on activated 
CD4+ T cells.18–21 The OX40L-OX40 signalling 
pathway is fundamental for effector T cell prolif-
eration and memory T cell development, mainte-
nance of cytokine production by T cells and DCs, 
increasing Ig production, and promoting plasma 
cell development.15 22–27 Nevertheless, how these 
various functions relate to the cell types expressing 
OX40L is still unclear. Constitutive expression of 
OX40L on T cells has been shown to induce spon-
taneous autoimmunity in C57BL/6 mice.23 A recent 
study showed that OX40L expression on a subset 
of myeloid DCs is implicated in the pathogenesis 
of SLE.28 The beneficial effect of blocking the 
OX40L-OX40 signalling pathway has been shown 
in several different mouse models of autoimmune 
diseases,17 but experimental evidence of its efficacy 
in SLE is unknown.
We sought to understand the function of OX40L 
using CD4+ T cell and B cell conditional knockout 
mice. We investigated the role of OX40L using 
immunisation and we went on to determine how 
the loss of OX40L affected the pathology in two 
different SLE mouse models.
MATERIALS AND METHODS
Mice
A bacterial artificial chromosome (BAC) clone 
encoding the extracellular domain and 3′-untrans-
lated region of Tnfsf4 was obtained from a 
C57BL/6-derived genomic library. The Tnfsf4 
conditional targeting vector was constructed 
using recombineering,29 as described in online 
supplementary figure S1A. The mice (Tnfsf4fl/fl) 
were made according to a standard gene targeting 
approach in A9 embryonic stem cells (ES). We 
used (129xC57BL/6)F1 ES; therefore, microsatel-
lite analyses were undertaken to confirm that the 
targeting vector had recombined on the C57BL/6 
chromosome. The mice were backcrossed for 
eight generations on the C57BL/6 background. 
Tnfsf4fl/fl mice were crossed with β-actin-cre, 
CD4-cre and CD19-cre (Jackson Laboratories) to 
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obtain Tnfsf4ïï, Tnfsf4fl/fl/CD4-cre and Tnfsf4fl/fl/CD19-cre, 
respectively. Before each experiment mice were genotyped by 
PCR. The primers and expected PCR product size are listed 
in supplementary table S1. B6.Sle16 mice were bred in-house 
and B6.Sle16.Tnfsf4ïï were generated by crossing them with 
Tnfsf4ïï mice. B6-H2bm12 mice were purchased from the 
Jackson Laboratories (B6(C).H2-Ab1bm12/KhEgJ; strain no. 
001162, https://www. jax. org/ strain/ 001162). The mice used 
were female, 8–12 weeks old and housed in specific patho-
gen-free conditions. All animal procedures were performed in 
accordance with institutional guidelines and approved by the UK 
Home Office.
In vitro analysis of OX40L expression
To assess OX40L expression in vitro, different cell subsets 
were purified from mouse spleen using LS Columns and MACS 
Technology (Miltenyi Biotec) and stimulated as described 
before.16 24 Briefly, single cell suspensions were obtained 
from collagenase-treated spleens, and B cells, DCs and T cells 
were then purified incubating the splenic cell suspension with 
anti-CD43(Ly-48) microbeads, anti-CD11c microbeads or 
CD4+ T cell isolation kit, respectively, following the manufac-
turers’ protocols. The purity of each subpopulation was tested 
routinely by fluorescence-activated cell sorting (FACS) and 
a value >95% was measured for each purification. Purified B 
cells and DCs were stimulated for 72 hours with anti-CD40 
(Clone3/23 at 2.5 µg/mL) plus F(ab’)2 anti-mouse IgM (10 µg/
mL) or anti-CD40 alone, respectively. T cells were stimulated 
with anti-CD3 (0.005 µg/mL), IL-2 (100 U/mL) and IL-12 (10 ng/
mL) for 7 days. After stimulation, the cells were harvested and 
analysed by FACS for OX40L expression.
Flow cytometry
Flow cytometry was performed using a five-colour or six-colour 
staining protocol and analysed with a BD FACSVerse (BD Biosci-
ences, San Jose, California, USA). The following Abs were used: 
anti-CD4 (GK.5), anti-CXCR5 (L138D7), anti-PD1(29F.1a12), 
anti-CD62L (MEL-14), anti-CD44 (IM7), anti-B220 (RA3-6B2), 
anti-GL7 (GL7), anti-CD138 (281-2) and anti-IgD (11–26 c.2a). 
Abs were purchased from BioLegend (San Diego, Cali-
fornia, USA). Staining was performed in the presence of a satu-
rating concentration of 2.4G2 mAb (anti-FcγRII/III). Data were 
analysed using FlowJo V.9 (Tree Star, Ashland, Oregon, USA).
Immunisation and ELISA
Mice were immunised subcutaneously with 50 µg 4-hydroxy-3-ni-
trophenylacetyl-chicken gamma globulin (NP-CGG) in complete 
Freund’s adjuvant. For the analysis of the secondary response 
mice were reimmunised with 50 µg of NP-CGG in incomplete 
Freund’s adjuvant 35 days after receiving the first immunisa-
tion. Serum was collected on days 7, 14, 28 and 42, and titres of 
isotype-specific low-affinity and high-affinity antibodies to NP 
were measured by ELISA in plates coated with either NP25-BSA 
or NP4-BSA (4-hydroxy-3-nitrophenylacetyl hapten conjugated 
to bovine serum albumin), respectively.30 Briefly NUNC plates 
were coated with the antigen at 5 µg/mL in borate buffered 
saline (BBS) overnight at 4°C. Plates were washed with phos-
phate buffered saline (PBS) and then blocked for 1 hour at room 
temperature with 0.5% BSA in PBS. Samples were diluted in 
dilution buffer (PBS 2%,  bovine serum albumin (BSA) 0.05% 
Tween-20) and added, in duplicate, to the plates for 3 hours at 
37°C. Plates were washed and incubated with alkaline phospha-
tase (AP)-conjugated secondary antibody specific for the different 
Ig isotype (SouthernBiotech) for 3 hours at room temperature. 
Plates were developed with p-nitrophenylphosphate (Sigma). A 
standard serum was generated from a pool of reactive serum of 
immunised wild-type mice. Absorbance was read at 405 nm and 
data were expressed as arbitrary ELISA unit (AEU) in reference 
to a standard curve obtained by serial dilution of the standard 
serum.
cGvHD mouse model and autoantibody assays
Knockout and control mice were injected intraperitoneally with 
5×107 splenocytes from B6.H2bm12 mice. Briefly, splenocytes 
were obtained as a single cell suspension by mashing the spleen 
collected through 70 µm cell strainers using the plunger from 
a syringe. After lysis of the red blood cells, splenocytes were 
counted and resuspended at 5×108 cells/mL in PBS and 100 µL 
was injected in each mouse. Serum was collected on days 14, 28 
and 42, and titres of IgG antibodies to double-stranded deoxyri-
bonucleic acid (dsDNA) were measured by ELISA using dsDNA 
(100 µg/mL) or single-stranded deoxyribonucleic acid (ssDNA) 
(10 µg/mL) in BBS buffer as coating antigen. Bound Abs were 
detected with AP-conjugated goat anti-mouse IgG (-chain 
specific) (Sigma-Aldrich) or IgM (Southern Biotechnology Asso-
ciates). The results were expressed as AEU relative to a standard 
positive sample derived from an MRL/Mplpr/ lpr mice pool.
Total serum IgG and IgM levels
Total serum IgM and IgG levels were assayed by capture ELISA 
as previously described.31
IgG, IgM and C3 kidney deposition
Fluorescein (FITC)-conjugated goat Abs against mouse total IgG 
(1/400 dilution; Sigma-Aldrich), mouse total IgM (1/200 dilu-
tion, eBioscience) and against mouse C3 (1/50 dilution; ICN 
Pharmaceuticals) were used on snap-frozen kidney sections. The 
staining with FITC-conjugated Abs was quantified as previously 
described31 and expressed as arbitrary fluorescence units.
Statistical analysis
Where appropriate either the Student’s t-test, two-way anal-
ysis of variance (ANOVA) or one-way ANOVA followed by 
Fisher’s least significant difference (LSD) multiple comparison 
test was performed using GraphPad Prism V.6.00 for Windows 
(GraphPad Software, La Jolla, California, USA).
RESULTS
Generation of Tnfsf4 conditional knockout strains
We generated a floxed Tnfsf4 mouse (Tnfsf4fl/fl) on the C57BL/6 
genetic background (see online supplementary figure S1A,B) to 
avoid the confounding effects caused by epistatic interactions 
between 129 and C57BL/6 genes that promote an autoimmune 
phenotype.32 Germline knockout (KO) mice were obtained by 
crossing Tnfsf4fl/fl with the β-actin Actb-cre mouse strain. Condi-
tional T cell Tnfsf4fl/fl(CD4)ïï and B cell Tnfsf4fl/fl(CD19)ïï 
specific knockout mice were created by crossing with CD4-cre33 
and CD19-cre mice,34 respectively. Lack of OX40L was observed 
in all cell types from Tnfsf4ïï mice, while a cell-specific dele-
tion was confirmed in the conditional knockouts (see online 
supplementary figure S1C).
B cell OX40L promotes antibody afﬁnity maturation
Conflicting data have been reported on the importance of the 
OX40L-OX40 pathway in controlling T-dependent antibody 
responses.24 26 35 Thus, we explored this response by immunising 
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the three KO strains and a control group with NP-CGG, a well-
studied T cell-dependent antigen. All three strains showed signifi-
cantly lower titres of low-affinity IgG2a and IgG2b antibodies 
against NP25-BSA compared with wild-type mice (figure 1A). 
In contrast, the IgG1 response was hardly affected by the lack 
of OX40L. Affinity maturation during the primary response 
was also assessed by measuring antibody against NP4-BSA on 
day 28 and by calculating the affinity maturation index (ratio 
of high-affinity to low-affinity antibody responses). All three 
knockout strains displayed lower titres of high-affinity IgG2a 
and IgG2b (figure 1B,C) compared with wild-type animals and 
a lower affinity maturation index (figure 1D), which suggested 
OX40L contribution in the antibody affinity maturation process. 
To investigate the role of OX40L in the secondary immune 
response, mice were then boosted with NP-CGG on day 35, and 
the high-affinity antibody response was measured 1 week later. 
Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï mice both showed a signifi-
cantly impaired IgG2a and IgG2b memory response compared 
with control mice, associated with a lower affinity maturation 
index (figure 1C,E). In contrast, the memory response in the 
Tnfsf4fl/fl(CD4)ïï mice was normal (figure 1C). These results 
indicate a role for both B and T cell OX40L in the primary 
immune response, with a distinct role for B cell OX40L in the 
affinity maturation of the secondary humoral immune response.
OX40L is essential for T cell activation
As the impaired humoral response could be a consequence 
of defective T cell activation, we decided to investigate the 
splenic T cell composition (see online supplementary figure 
S2A) of immunised mice on days 14 and 42 (figure 2). By day 
14, Tnfsf4ïï and Tnfsf4fl/fl(CD4)ïï had a markedly lower 
proportion of effector T and effector/memory CD4+ T cells. 
In contrast, Tnfsf4fl/fl(CD19)ïï mice showed only a reduction 
in the proportion of effector/memory T cells, indicating that 
B cell OX40L may not play a major role in priming naïve T 
Figure 1 OX40L in T cell-dependent humoral response. Wild-type controls, Tnfsf4−/−, Tnfsf4ﬂ/ﬂ(CD19)−/− and Tnfsf4ﬂ/ﬂ(CD4)−/− mice were immunised 
with NP-CGG in CFA and reimmunised on day 35 with NP-CGG in IFA. Sera were collected on days 7, 14 and 28 for the primary response and on day 
42 for the secondary response. (A) Titres of NP-speciﬁc low-afﬁnity antibody measured with NP25-BSA. (B) Titres of NP-speciﬁc high-afﬁnity antibodies 
on day 28 measured with NP4-BSA. (C) Titres of NP-speciﬁc high-afﬁnity antibodies on day 42 measured with NP4-BSA. (D) Afﬁnity maturation index 
calculated as ratio of the titres of IgG detected with NP4-BSA to those with NP25-BSA on day 28. (E) Afﬁnity maturation index calculated as the ratio 
of the titres of IgG detected with NP4-BSA to those with NP25-BSA on day 42. Each symbol represents an individual mouse; dots in (A) and bars in 
(B–E) indicate the mean titre, each being shown mean±SEM. AEU is arbitrary ELISA unit; N.S. is not signiﬁcant; *p<0.05, **p<0.01 and ***p<0.001 
(A, two-way ANOVA; B–E, one-way ANOVA). ANOVA, analysis of variance; CFA, complete Freund’s adjuvant; IFA, incomplete Freund’s adjuvant; NP-
CGG, nitrophenylacetyl-chicken gamma globulin; NP25-BSA, NP4-BSA, 4-Hydroxy-3-nitrophenylacetyl hapten conjugated to bovine serum albumin.
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cells. On day 42, all three knockout strains had fewer T effector 
cells than control mice (figure 2). Interestingly, Tnfsf4ïï and 
Tnfsf4fl/fl(CD19)ïï mice also showed a small, but statistically 
significant, increment in the frequency of central memory T 
cells, suggesting that OX40L may regulate the balance between 
effector and central memory T cells during the recall response 
(figure 2). Our data confirmed the previous reported role of 
OX40-OX40L signalling in T cell activation and development 
of T effector memory cells.18 22 23 36 The explanation for the 
difference in the secondary humoral response between Tnfsf4fl/
fl(CD4)ïï and Tnfsf4fl/fl(CD19)ïï mice was not evident. We 
therefore decide to investigate further analysing the extent of 
the germinal centre (GC) reaction in the immunised mice.
OX40L on B cells supports plasma cell development
All three groups of immunised KO mice showed no difference 
in the GC B cell population (see online supplementary figure 
S2B) on day 14 (figure 3A), although during the secondary 
response, 1 week after the rechallenge, Tnfsf4ïï mice showed a 
smaller proportion of GC B cells (figure 3A). Similarly, no differ-
ences were detected in the plasma cell frequency on day 14, but 
Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï mice showed a significantly 
lower percentage of plasma cells on day 42 (figure 3B).
B cell OX40L is essential for T
FH
 maturation
Having demonstrated the importance of OX40L in T cell acti-
vation and in plasma cell development, we investigated its 
possible role in T follicular helper cell (T
FH
) maturation. We 
identified the GC T
FH
 population as a subset of CD4+ T cells 
expressing CXCR5 and high levels of PD-1 (CXCR5+PD-1hi) 
(figure 3C,F), and in figure 3G the frequencies of splenic GC T
FH
 
cells (as a proportion of CD4+ T cells) following immunisation 
are illustrated. There were fewer GC T
FH
 cells in the spleens 
of Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï compared with wild-type 
mice during both the primary and secondary responses. In 
contrast, no differences were observed between controls and 
Tnfsf4fl/fl(CD4)ïï mice. Both Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï 
mice showed a reduction in the expression levels of PD1 at both 
time points, and importantly displayed a greater frequency of 
CXCR5+ PD1low cells (T
FH
 precursors) in the CD4+ popula-
tion compared with control mice on day 42 (figure 3D,F). Inter-
estingly, Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï mice also revealed a 
reduced number of CXCR5+ cells during the primary (day 14) 
but not the secondary response (day 42) (figure 3E).
Lack of OX40L reduces T
FH
 number and ameliorates the lupus 
phenotype
In view of the genetic association of TNFSF4 and SLE and the 
functional results outlined above, we investigated the effect 
of loss of OX40L in SLE using two different mouse models: a 
congenic model and a graft-versus-host model.
Tnfsf4ïï mice were crossed with B6.Sle16 lupus-prone mice, 
which are characterised by development of humoral autoimmu-
nity associated with splenomegaly, high level of total IgG and 
IgM, autoantibodies production and glomerulonephritis linked 
to Ig and C3 deposition in the kidney.31 32 The resultant B6.
Sle16.Tnfsf4ïï female animals were monitored for 9 months 
(figure 4). The absence of OX40L was associated with a marked 
reduction in splenomegaly (figure 4A,B) and a lower serum level 
of total IgG and IgM (figure 4C). No detectable levels of IgG 
anti-DNA were observed either in the knockout or the B6.Sle16 
control group. However, when we analysed IgM anti-ssDNA 
autoantibodies, a significant lower titre was observed in mice 
lacking OX40L compared with the B6.Sle16 group (figure 4D). 
To investigate the effect of loss of OX40L on target organs, we 
quantified glomerular IgG, IgM and complement C3. As expected 
fluorescent quantification revealed significantly lower amount 
of IgG and IgM deposition in the glomerular in the absence of 
OX40L; in contrast a similar level of C3 deposition was observed 
(see online supplementary figure S3). Mice lacking OX40L had 
less T cell activation and higher proportions of central memory 
and naïve T cells (CD62L+ CD44hi cells) (figure 4E). Consis-
tent with the immune response data (figure 3), the B6.Sle16.
Tnfsf4ïï showed a fivefold reduction, relative to the B6.Sle16 
mice, in the proportion of CD4+ T
FH
 cells (figure 4F), along 
with a dramatic reduction of PD-1 expression on CD4+ cells 
(figure 4G). Furthermore, the percentage of plasma cells and 
GC B cells (B220+ IgD GL7+) was also significantly lower in 
the absence of OX40L (figure 4H,I).
We then used the I-Abm12 chronic graft-versus-host-
disease (cGvHD) mouse model, in which an allogeneic 
interaction of T and B cells expressing different major 
histocompatibility complex (MHC) class II (I-A) induces an 
SLE-like phenotype.37 38 As shown in figure 5A, Tnfsf4ïï and 
Tnfsf4fl/fl(CD19)ïï mice injected with B6.H2-Ab1bm12 sple-
nocytes developed a lower titre of IgG anti-dsDNA compared 
with controls. In addition, both knockout groups showed 
a lower percentage of effector/memory T and T
FH
 cells 
(figure 5B,C). A trend towards a lower percentage of plasma 
Figure 2 Role of OX40L in T cell activation. Wild-type controls, Tnfsf4−/−, Tnfsf4(CD19)−/− and Tnfsf4(CD4)−/− mice were immunised with NP-CGG in 
CFA and reimmunised on day 35 with NP-CGG in IFA. Spleens were taken and analysed by FACS either on day 14 or day 42. Quantiﬁcation of naïve 
(CD4+, CD62L+, CD44low) T cells, effector (CD4+, CD62Llow, CD44low) T cells, effector/memory (CD4+, CD62Llow/neg, CD44hi) T cells and central/memory 
(CD4+, CD62L+, CD44hi) T cells on day 14 (left) and day 42 (right). Each symbol represents an individual mouse. Bars indicate the mean±SEM. N.S., 
not signiﬁcant; *p<0.05, **p<0.01 and ***p<0.001 (one-way analysis of variance). CFA, complete Freund’s adjuvant; FACS, ﬂuorescence-activated 
cell sorting; IFA, incomplete Freund’s adjuvant; NP-CGG, nitrophenylacetyl-chicken gamma globulin. 
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and GC B cells was observed in both OX40L-deficient groups 
(figure 5D,E). Of note, no differences were seen between 
Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï mice, indicating that the 
observed differences are primarily due to the lack of OX40L 
on B cells.
DISCUSSION
The TNFSF4 locus (that encodes OX40L) shows association with 
several autoimmune diseases; it has one of the most consistent 
and strongest genetic risk factors in SLE. OX40L has a well-estab-
lished role in the activation and maintenance of T cell-mediated 
Figure 3 OX40L function in GC reaction. Wild-type controls, Tnfsf4−/−, Tnfsf4(CD19)−/− and Tnfsf4(CD4)−/− mice were immunised with NP-CGG in 
CFA and reimmunised on day 35 with NP-CGG in IFA. Spleens were taken and analysed by FACS either on day 14 or day 42. (A) Frequency of GC 
B cell (B220+, GL7+, IgD−) presented as frequency among the B220+ population. (B) Percentage of plasma cells (B220low, CD138hi). (C) Gating of 
T follicular helper (T
FH
) (CD4+, CXCR5+, PD-1hi) and pre-T follicular helper (pre-T
FH
) (CD4+, CXCR5+, PD-1Low/neg) cells. (D) PD-1 expression level in 
CD4+ cells assessed by FACS. (E) Frequency of CXCR5+ cells presented as frequency among the CD4+ population. (F) Quantiﬁcation of pre-GC T
FH
 
and (G) GC-T
FH
 cells as gated in (C) presented as frequency among the CD4+ population. Each symbol represents an individual mouse. Bars indicate 
the mean±SEM, N.S., not signiﬁcant; *p<0.05, **p<0.01 and ***p<0.001 (one-way analysis of variance). CFA, complete Freund’s adjuvant; FACS, 
ﬂuorescence-activated cell sorting; GC, germinal centre; IFA, incomplete Freund’s adjuvant; NP-CGG, nitrophenylacetyl-chicken gamma globulin. 
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immune responses. However, the diversity of cells that express 
OX40L is such that a pathogenic mechanism relating the genetic 
findings to disease has not been clearly established. In this study, 
we generated B and CD4+ T cell OX40L conditional knockout 
mice, alongside a complete OX40L knockout, to explore and 
compare the function of OX40L on these cells.
Although a role for OX40L in the T-dependent antibody 
response has been suggested, conflicting results using different 
OX40L-deficient mice have been reported.24 35 These contra-
dictory results may be partly explained by variability in genetic 
background.39 Our conditional knockout mice were on a pure 
C57BL/6 background and, in accord with the one study,24 
Figure 4 OX40L deﬁciency ameliorates the phenotype of B6.Sle16 lupus-prone mice. Comparison between female B6.Sle16 and B6.Sle16.
Tnfsf4
−/− female mice at 9 months of age. (A) Quantitation of spleen/body weight ratio and spleen weight. (B) Absolute number of cells per spleen. 
(C) Serum level of IgG and IgM at 6 and 9 months. (D) Titre of IgM anti-dsDNA and anti-ssDNA. (E) Quantitation of naïve (T
N
) (CD4+, CD62L+, 
CD44low), (T
EFF
) effector (CD4+, CD62Llow, CD44low), T
EM
 effector/memory (CD4+, CD62Llow/neg, CD44hi) and T
CM
 central/memory (CD4+, CD62L+, CD44hi) 
T cells expressed as a percentage of CD4+ cells and absolute number. (F) GC T
FH
 cells (CD4+, CXCR5+, PD-1hi) presented as frequency among the 
CD4+ population and absolute number. (G) PD-1 expression level in CD4+ cells assessed by FACS. (H) GC B cell (B220+, GL7+, IgD−) presented as 
frequency among the B220+ population and absolute number. (I) Percentage and absolute number of plasma cells (B220low, CD138hi). Each symbol 
represents an individual mouse. Bars indicate the mean±SEM N.S., not signiﬁcant; *p<0.05, **p<0.01 and ***p<0.001 (t-test). dsDNA, double-
stranded deoxyribonucleic acid; FACS, ﬂuorescence-activated cell sorting; GC, germinal centre; ssDNA, single-stranded deoxyribonucleic acid. 
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our Tnfsf4ïï mice showed a reduced primary and secondary 
antibody response. However, while the Tnfsf4fl/fl(CD19)ïï 
mice showed the same phenotype as the Tnfsf4ïï mice, the 
Tnfsf4fl/fl(CD4)ïï mice had a normal secondary response, indi-
cating that only OX40L expression by B cells is essential for the 
generation of an effective secondary humoral response and by 
implication B cell memory. We then investigated whether this 
defective humoral response was due to impaired T cell activa-
tion; as expected, Tnfsf4ïï mice showed lower percentage of 
T effector and T effector memory cells (figure 2). The same 
defect, although at a lower extent, was also shown by both 
conditional knockouts, despite the normal secondary response in 
Tnfsf4fl/fl(CD4)ïï mice. These results suggest that B cell OX40L 
may be involved in biological processes that promote memory 
responses that are independent of T cell activation.
T cell-dependent B cell immune response involves both an 
extrafollicular response, which generates short-lived plasma cells 
and an early wave of low-affinity antibody production, and a 
GC response, which gives rise to long-lived plasma or memory 
cells and a later wave of high-affinity antibodies. OX40L has 
been previously suggested to be essential for the development 
of high-affinity Ig-producing plasma cells26; however, no further 
evidence has been subsequently reported. In our study, along-
side an impaired memory response (figure 1C), there were fewer 
plasma cells on day 42 in Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï mice 
(figure 3B), which suggests that B cell OX40L contributes to an 
effective GC reaction.
We show that Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï mice have a 
lower percentage of GC T
FH
, one of the main contributors to 
the GC reaction. The development of mature GC T
FH
, which 
characteristically expresses CXCR5, along with high levels of the 
surface receptors ICOS, CD40 ligand (CD40L), PD-1 and impor-
tantly OX40,40 41 includes two stages: after activation, a fraction 
of CD4+ T cells migrate towards B cell follicles by upregulating 
the chemokine receptor CXCR5, and these T
FH
 precursors then 
interact with antigen-presenting B cells at the border of the B cell 
follicle and T cell zone and fully maturate into functional GC 
T
FH
 cells.41 In particular OX40L has been shown to be essential 
for the expression of CXCR5 and the consequent migration of 
T cells at the T/B border of B cell follicles,22 42 43 providing the 
first evidence of the role of OX40L in this process. Our results 
corroborate this finding; we found that fewer CXCR5+ T cells 
were generated during the primary response in Tnfsf4ïï and 
Tnfsf4fl/fl(CD19)ïï mice (figure 3E). Whether OX40L-OX40 
signal is responsible for the induction, maturation or mainte-
nance of T
FH
 cells and which cell types expressing OX40L are 
necessary is still unclear; however, a recent work by Tahiliani 
and colleagues44 shows a markedly diminished humoral response 
and production of fewer T
FH
 cells in OX40 KO mice following 
immunisation with vaccinia virus. In particular the authors show 
a direct association between OX40+ T
FH
 cells and OX40L-ex-
pressing DCs and B cells at the T/B borders and GC providing 
supportive evidence to how a sustained OX40L-OX40 signal on 
T
FH
 cells is necessary for the induction of T
FH
 cells and their 
Figure 5 OX40L deﬁciency diminishes anti-dsDNA antibody production in the cGvHD model. Female wild-type controls, Tnfsf4−/− and 
Tnfsf4(CD19)−/− mice were injected intraperitoneally with 5×107 splenocytes from B6.H2bm12 female mice. Sera were collected on days 14, 28, 42 
and 56. On day 56, spleens were collected and analysed by FACS. (A) Titre of IgG anti-dsDNA in the sera of injected mice at different time points. (B) 
Quantiﬁcation of naïve (T
N
) (CD4+, CD62L+, CD44low), (T
EFF
) effector (CD4+, CD62Llow, CD44low), (T
EM
) effector/memory (CD4+, CD62Llow/neg, CD44hi) 
and (T
CM
) central/memory (CD4+, CD62L+, CD44hi) T cells expressed as percentage of CD4+ cells. (C) Quantiﬁcation of GC T
FH
 cells (CD4+, CXCR5+, 
PD-1hi) presented as frequency among the CD4+ population. (D) Frequency of GC B cells (B220+,GL7+, IgD−) presented as frequency among the 
B220+ population. (E) Percentage of plasma cells (B220low, CD138hi). Each symbol represents data from an individual mouse. Bars indicate the 
mean±SEM. N.S., not signiﬁcant; *p<0.05, **p<0.01 and ***p<0.001 (one-way analysis of variance). cGvHD, chronic graft-versus-host-disease; 
dsDNA, double-stranded deoxyribonucleic acid; FACS, ﬂuorescence-activated cell sorting; GC, germinal centre.
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maturation to maintain a proper GC reaction. In our study, the 
reduced numbers of T
FH
 cells in Tnfsf4ïï and Tnfsf4fl/fl(CD19)ïï 
mice were accompanied by an increase in CXCR5+ PD1low cells 
during the secondary response (figure 3F,G). Since low levels of 
cell-surface PD1 have been shown to characterise T
FH
 precursor 
cells,45 our data suggest a novel role for OX40L on B cells: after 
activation by DCs, immature T
FH
 cells migrate towards the T/B 
borders of the B cells follicles, where activated antigen presenting 
B cells induced their maturation into the GC T
FH
 resident state 
and their maintenance by sustaining OX40L-OX40 signalling.
TNFSF4 has been reproducibly associated with SLE.4 5 A 
recent important study from Jacquemin and colleagues28 demon-
strated that stimulation through OX40 induced T cells to 
express T
FH
 cells-specific genes such as Bcl6 and CXCR5. They 
also observed a positive correlation between disease activity, 
percentage of blood T
FH
 cells and frequency of OX40L+my-
eloid APC, suggesting OX40L-OX40 axis as a contributor factor 
in the aberrant T
FH
 response observed in SLE.46 47 However, the 
ability to study tissue T
FH
 in humans is limited. In our study, 
although in a murine model, the generation of T
FH
 cells in the 
spleen is similarly impeded in the B cell conditional knockout 
and in the germline Tnfsf4 knockout, indicating the importance 
of B cell OX40L. In the human study,28 there was no correla-
tion between blood B cells expressing OX40L and T
FH
 cells. 
However, this lack of correlation could be a consequence of the 
compartmentalisation of activated B cells expressing OX40L in 
the secondary lymphoid organs rather than an evidence of their 
lack of involvement in the development of pathogenic T
FH
 cells 
in SLE.
In our study, to elucidate the role of OX40L in SLE, we used 
two different SLE mouse models, and in particular the GvHD 
model was chosen to investigate the role of OX40L on B cells 
during the B–T cell interaction. In both models of systemic 
autoimmunity, the lack of OX40L-OX40 signalling was associ-
ated with amelioration of the disease phenotype, as shown by a 
reduced production of anti-dsDNA autoantibodies and Ig kidney 
deposition together with reduced numbers of GC T
FH
 (figures 4F 
and 5C) and plasma cells (figures 4I and 5E). These data suggest 
that OX40L supports the expression of the disease phenotype 
as well as autoantibody production. This conclusion is further 
strengthened by the observation that blockade of OX40L reduces 
degree of proteinuria associated with glomerulonephritis in an 
accelerated murine model.48
The results presented in this paper support a mechanism by 
which genetically determined elevated expression of OX40L 
predisposes to SLE via increased B cell expression, which in 
turn supports T
FH
 development. In light of the argument that 
genetic factors augment the likelihood of success with a drug 
target,49 our data strongly support exploration of this thera-
peutic strategy. It is potentially important for optimal treatment 
to know which OX40L-expressing cell types should be targeted, 
and the defined risk alleles at TNFSF4 further raise the possi-
bility that genetic screening may identify individuals most likely 
to benefit from OX40L inhibition.
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